Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CDK2 | P24941 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 5/20 | 0.33 |
| ▸ | TYMS | P04818 | 4/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL152384 | 1.00 | MEN1 (0.70) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL63456 | 0.87 | TDP1 (0.69) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL30823023 | 0.87 | MEN1 (0.65) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL29359581 | 0.87 | MEN1 (0.65) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL4949654 | 0.87 | MEN1 (0.65) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL1554463 | 0.87 | TDP1 (0.69) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL14905229 | 0.87 | MEN1 (0.65) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL29390175 | 0.87 | TDP1 (0.69) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL16303141 | 0.87 | MEN1 (0.65) | MEN1LMNAKMT2ACYP1A2CYP2C9 | |
| SCHEMBL30823024 | 0.87 | MEN1 (0.65) | MEN1LMNAKMT2ACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11236234-B2 | Joint compounds and plasters with a complexometric dye and methods | UNITED STATES GYPSUM COMPANY (US) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11236234-B2 | Joint compounds and plasters with a complexometric dye and methods | LCP1, INTS6, PLOD2 | MEN1 888/4885LMNA 2490/4885KMT2A 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.